Keiretsu Forum Invests $3 Million in Savara Pharmaceuticals

The Keiretsu Forum’s members gave $3 million as the lead investor on a Series B round for Savara Pharmaceuticals. Savara is developing pulmonary drugs to treat serious and life threatening conditions. “The opportunity to invest in Savara Pharmaceuticals attracted many of our accredited investors, who are deeply committed to supporting products and technologies with the […]